A pregnant pause to consider teratogenicity of topiramate
- PMID: 19421375
- PMCID: PMC2673401
- DOI: 10.1111/j.1535-7511.2008.01284.x
A pregnant pause to consider teratogenicity of topiramate
Comment on
-
Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.Neurology. 2008 Jul 22;71(4):272-6. doi: 10.1212/01.wnl.0000318293.28278.33. Neurology. 2008. PMID: 18645165
References
-
- Meador KJ, Pennell PB, Harden CL, Gordon JC, Tomson T, Kaplan PW, Holmes GL, French JA, Hauser WA, Wells PG, Cramer JA, HOPE Work Group Pregnancy registries in epilepsy: A consensus statement on health outcomes. Neurology. 2008;71:1109–1117. - PubMed
-
- Ornoy A, Zvi N, Arnon J, Wajnberg R, Shechtman S, Diav-Citrin O. The outcome of pregnancy following topiramate treatment: A study on 52 pregnancies. Reprod Toxicol. 2008;25:388–389. - PubMed
-
- Dolk H, Jentink J, Loane M, Morris J, de Jong-van den Berg LT, EUROCAT Antiepileptic Drug Working Group Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology. 2008;71:714–722. - PubMed
-
- Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB, Antiepileptic Drug Pregnancy Registry Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology. 2005;64:961–965. - PubMed
-
- Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001;344:1132–1138. - PubMed
Publication types
LinkOut - more resources
Full Text Sources